• Citer

Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial

par Gelber, Richard;Wang, Xin Victoria;Cole, Bernard B.F.;Cameron, David A;Cardoso, Fatima ;Tjan-Heijnen, Vivianne C G;Krop, Ian;Loi, Sherene ;Salgado, Roberto;Kiermaier, Astrid;Frank, Elizabeth E.S.;Fumagalli, Debora ;Caballero, Carmela;de Azambuja, Evandro ;Procter, Marion;Clark, Emma;Restuccia, Eleonora;Heeson, Sarah;Bines, Jose;Loibl, Sibylle;Piccart-Gebhart, Martine
Référence European journal of cancer, 166, page (219-228)
Publication Publié, 2022-05

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial
Auteur:	Gelber, Richard; Wang, Xin Victoria; Cole, Bernard B.F.; Cameron, David A; Cardoso, Fatima; Tjan-Heijnen, Vivianne C G; Krop, Ian; Loi, Sherene; Salgado, Roberto; Kiermaier, Astrid; Frank, Elizabeth E.S.; Fumagalli, Debora; Caballero, Carmela; de Azambuja, Evandro; Procter, Marion; Clark, Emma; Restuccia, Eleonora; Heeson, Sarah; Bines, Jose; Loibl, Sibylle; Piccart-Gebhart, Martine
Informations sur la publication:	European journal of cancer, 166, page (219-228)
Statut de publication:	Publié, 2022-05
Sujet CREF:	Cancérologie
Mots-clés:	Adjuvant therapy
	HER2-positive early breast cancer
	Pertuzumab
	STEPP (Subpopulation Treatment Effect Pattern Plot)
	TILs (tumour infiltrating lymphocytes)
	Trastuzumab
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0959-8049
	info:doi/10.1016/j.ejca.2022.01.031
	info:pii/S0959804922000648
	info:scp/85126564916